Patents Assigned to Thomas Jefferson University
-
Publication number: 20230044615Abstract: One aspect of the invention provides a method for freeze-drying surfactant-stabilized microbubbles. The method includes: preparing vials comprising a mixture comprising microbubbles; partially submerging the vials in a chilled water bath, wherein the water bath has a sub-freezing temperature; placing the vials on a cooled shelf of a lyophilizer; freeze-drying the vials in the lyophilizer; and capping the freeze-dried vials. Another aspect of the invention provides a method for annealing surfactant-stabilized microbubbles. The method includes: preparing vials comprising a mixture comprising microbubbles; passing the vials in and out of liquid nitrogen (LN2) until the mixture is frozen; holding the vials at ?20° C.; placing the vials on a cooled shelf of a lyophilizer; freeze-drying the vials in the lyophilizer; and capping the freeze-dried vials.Type: ApplicationFiled: June 30, 2022Publication date: February 9, 2023Applicants: Thomas Jefferson University, Drexel UniversityInventors: Brian Edward Oeffinger, Margaret A. Wheatley, Rawan Shraim, Purva Vaidya, John Robert Eisenbrey
-
Patent number: 11571483Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.Type: GrantFiled: September 3, 2020Date of Patent: February 7, 2023Assignee: THOMAS JEFFERSON UNIVERSITYInventors: Andrew Aplin, Jessica Teh
-
Patent number: 11567065Abstract: A method for detecting and quantifying of the frequency of T cells to multiple antigenic peptide epitopes comprising: measuring intracellular Ca2+ signaling in individual T cells that are labeled with Ca2+ sensitive fluorophore; wherein said T cells are placed on the glass bottom of a well-covered with antibodies or other capturing proteins specific for non-stimulatory T cells' surface receptors and wherein a peptide antigens are injected into the well and the peptide binds to MHC molecules on the T-cell surface, wherein an increase in the intracellular concentration of Ca2+ in responding T cells leads to rise in intracellular fluorescence that is detected by fluorescent microscope and wherein the response rate of said detected fluorescence can be utilized to determine the quantity of responding T cells and the efficiency of said cells.Type: GrantFiled: June 24, 2016Date of Patent: January 31, 2023Assignee: Thomas Jefferson UniversityInventors: Yuri Sykulev, Nadezhda Anikeyeva, Neal Flomenberg, Dolores Grosso
-
Patent number: 11540883Abstract: Systems and methods for virtual reality (VR) training of medical events are described herein. In one aspect, a method for generating a VR medical training environment can include displaying a medical event through a VR headset, receiving, from a user of the VR headset, a set of verbal responses corresponding to the user reacting to the medical event, determining a timestamp for at least one verbal response received from the user, determining a medical event score for the user based on the set of verbal responses and the timestamp, and displaying a summary of the medical event score via the VR headset or a display screen.Type: GrantFiled: March 9, 2020Date of Patent: January 3, 2023Assignee: Thomas Jefferson UniversityInventors: Timothy G. Moyer, Pavitra Krishnamani, Corey B. Fischer, Daniel Holmes, Tejal Naik
-
Patent number: 11535888Abstract: A method for specifically and efficiently quantifying the expression of targeted RNA variants with specific terminal sequences suitable to identify multiple isoforms bearing complex heterogeneity in terminal sequences by hybridizing a 5?-Dbs-adapter to the 5?-end of target RNAs, wherein the 5?-Dbs-adapter has a stem-loop structure whose protruding 5?-end base-pairs with the 5?-end of target RNAs, and wherein the loop region of 5?-Dbs-adapter contains a base-lacking spacer which will terminate reverse transcription in a subsequent step; hybridizing a 3?Db-adapter to the 3?-end of target RNAs, wherein the 3?-Db-adapter has a stem-loop structure whose protruding 3?-end base-pairs with the 3?-end of target RNAs; ligating both adapters with target RNAs by RN12 ligation to form a “dumbbell-like” structure; and, amplifying and quantifying the ligation product by RT-PCR.Type: GrantFiled: August 22, 2016Date of Patent: December 27, 2022Assignee: THOMAS JEFFERSON UNIVERSITYInventors: Yohei Kirino, Shozo Honda
-
Publication number: 20220401454Abstract: A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.Type: ApplicationFiled: July 7, 2022Publication date: December 22, 2022Applicant: Thomas Jefferson UniversityInventors: Janice L. Walker, Alexander Mazo, Svetlana Petruk, A. Sue Menko
-
Patent number: 11529076Abstract: A method of monitoring respiration with an acoustic measurement device, the acoustic measurement device having a sound transducer, the sound transducer configured to measure sound associated with airflow through a mammalian trachea, the method includes correlating the measured sound into a measurement of tidal volume and generating at least one from the group consisting of an alert and an alarm if the measured tidal volume falls outside of a predetermined range.Type: GrantFiled: October 11, 2021Date of Patent: December 20, 2022Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I Joseph, Noud Van Helmond, Marc C Torjman, Denise L Devine, Nance K Dicciani, Channy Loeum
-
Patent number: 11510606Abstract: A device and a signal processing method that can be used with a device to recognize and distinguish a physiological high-frequency oscillation (HFO) from a pathological high-frequency oscillation. The signal processing method detects a physiological HFO in the electrical brain signal one regimen of electrical or optogenetic brain stimulation can be triggered, alternatively if the method detects a pathological HFO associated with epilepsy a different regimen of electrical or optogenetic brain stimulation can be triggered. Thus, the signal processing method can be utilized in a closed loop brain stimulation device that serves the dual purpose of both enhancing memory encoding, consolidation, and recall, or improving cognition, and reducing the probability of a seizure in a patient with epilepsy.Type: GrantFiled: December 4, 2017Date of Patent: November 29, 2022Assignee: THOMAS JEFFERSON UNIVERSITYInventors: Shennan Weiss, Zachary Waldman, Inkyung Song
-
Patent number: 11484505Abstract: This invention provides compositions comprising at least one protein nanoparticle comprising a protein and a stealth polymer. In certain embodiments, the nanoparticle further comprises a therapeutic agent, such as but not limited to a miRNA and/or siRNA. In other embodiments, the nanoparticle further comprises a cell surface receptor ligand. Also included in the invention are methods of preparing the compositions of the present invention, and methods of treating, ameliorating or preventing a disease or disorder in a subject using the compositions of the present invention.Type: GrantFiled: October 13, 2017Date of Patent: November 1, 2022Assignee: Thomas Jefferson UniversityInventor: Sunday Shoyele
-
Patent number: 11484586Abstract: The present disclosure is directed towards chimeric glycoproteins wherein the clip region, a core region, a flap region, and a transmembrane and cytoplasmic domain are defined by starting from the amino terminus of the protein, these domains are comprised of the following amino acid residue ranges: clip, 1 through 40 to 60; core, 40 to 60 through 249 to 281; flap, 249 to 281 through 419 to 459; the transmembrane domain is comprised of amino acids 460 through 480, and the remaining amino acids 481 through 525 comprise the cytoplasmic domain; and wherein the clip, core, flap, transmembrane, and cytoplasmic domain comprise a chimeric combination of at least two lyssavirus, wherein the chimeric glycoprotein is advantageously inserted into a rabies-based vaccine vector.Type: GrantFiled: June 13, 2018Date of Patent: November 1, 2022Assignees: Thomas Jefferson University, ICAHN School of Medicine at Mount SinaiInventors: Matthias Schnell, Christine Rettew Fisher, Christoph Wirblich, Gene Tan
-
Patent number: 11478543Abstract: The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.Type: GrantFiled: March 5, 2021Date of Patent: October 25, 2022Assignee: Thomas Jefferson UniversityInventors: Matthias J. Schnell, Christoph Wirblich, Drishya Kurup
-
Patent number: 11445924Abstract: An implantable vital sign sensor including a housing including a first portion, the first portion defining a first open end, a second open end opposite the first end, and a lumen there through, the first portion being sized to be implanted substantially entirely within the blood vessel wall of the patient. A sensor module configured to measure a blood vessel blood pressure waveform is included, the sensor module having a proximal portion and a distal portion, the distal portion being insertable within the lumen and the proximal portion extending outward from the first open end.Type: GrantFiled: August 1, 2019Date of Patent: September 20, 2022Assignee: Thomas Jefferson UniversityInventor: Jeffrey I. Joseph
-
Patent number: 11433039Abstract: The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RAR? agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.Type: GrantFiled: April 9, 2019Date of Patent: September 6, 2022Assignee: Thomas Jefferson UniversityInventors: Masahiro Iwamoto, Maurizio Pacifici
-
Publication number: 20220267409Abstract: Heterodimers are provided. Accordingly, there is provided a heterodimer comprising a dimerizing moiety attached to at least one amino acid sequence of at least one type I membrane protein capable of at least binding a natural ligand or receptor of said at least one type I membrane protein and to at least one amino acid sequence of at least one type II membrane protein capable of at least binding a natural ligand or receptor of said at least one type II membrane protein. Also provided are nucleic acid constructs and systems encoding the heterodimer, host-cells expressing same and methods of use thereof.Type: ApplicationFiled: July 8, 2020Publication date: August 25, 2022Applicants: KAHR Medical Ltd., Thomas Jefferson UniversityInventors: Mark L. TYKOCINSKI, Ami TAMIR, Edwin BREMER
-
Publication number: 20220249667Abstract: The present invention provides methods for preparing acoustically-sensitive microbubbles. The method includes the steps of: i) preparing a first surfactant solution comprising a first micelle-forming surfactant at a concentration above the critical micelle concentration (CMC); ii) adding one or more pharmaceutical compounds in a solvent to the first surfactant solution, thereby loading the micelles with the one or more pharmaceutical compounds; iii) preparing a second surfactant solution comprising a second surfactant, wherein the second surfactant comprises one or more matrix forming surfactants; iv) adding heat to the second surfactant solution to melt the surfactant and allowing the mixture to cool under rapid stirring; v) combining the second surfactant solution with the loaded micelles; vi) purging the surfactant mixture with a purging gas; vii) agitating the purged mixture under a constant stream of the purging gas; and, viii) separating the formed microbubbles by size.Type: ApplicationFiled: May 29, 2020Publication date: August 11, 2022Applicants: Drexel University, Thomas Jefferson UniversityInventors: Margaret A. Wheatley, John Robert Eisenbrey, Brian E. Oeffinger, Purva Vaidya
-
Publication number: 20220256682Abstract: Applications of dielectric barrier discharge (DBD) based atmospheric pressure plasma jets are often limited by the relatively small area of treatment due to their 1D configuration. This system generates 2D plasma jets permitting fast treatment of larger targets. DBD evolution starts with formation of transient anode glow, and continues with development of cathode-directed streamers. The anode glow can propagate as an ionization wave along the dielectric surface through and outside of the discharge gap. Plasma propagation is not limited to 1D geometry such as tubes, and can be organized in a form of a rectangular plasma jet, or other 2D or 3D shapes. Also described are a method for generating 2D plasma jets and use of the 2D plasma jets for cancer therapy.Type: ApplicationFiled: January 3, 2022Publication date: August 11, 2022Applicants: Drexel University, Thomas Jefferson UniversityInventors: Danil V. DOBRYNIN, Alexander FRIDMAN, Abraham LIN, Vandana MILLER, Adam Snook
-
Patent number: 11400099Abstract: A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.Type: GrantFiled: September 25, 2017Date of Patent: August 2, 2022Assignee: THOMAS JEFFERSON UNIVERSITYInventors: Janice L. Walker, Alexander Mazo, Svetlana Petruk, A. Sue Menko
-
Patent number: 11395927Abstract: An immobilization apparatus having at least one or more straps that engage a surface; wherein at least one of the straps comprises a force gauge to determine the amount of force applied to a patient immobilized with said straps; wherein the position of the patient is replicable for treatment of radiation and other head or neck treatments.Type: GrantFiled: January 22, 2018Date of Patent: July 26, 2022Assignee: THOMAS JEFFERSON UNIVERSITYInventors: Hyun Kim, Voichita Bar Ad, Amy Taylor, Shivank Garg
-
Patent number: 11389552Abstract: One aspect of the invention provides a method for freeze-drying surfactant-stabilized microbubbles. The method includes: preparing vials comprising a mixture comprising microbubbles; partially submerging the vials in a chilled water bath, wherein the water bath has a sub-freezing temperature; placing the vials on a cooled shelf of a lyophilizer; freeze-drying the vials in the lyophilizer; and capping the freeze-dried vials. Another aspect of the invention provides a method for annealing surfactant-stabilized microbubbles. The method includes: preparing vials comprising a mixture comprising microbubbles; passing the vials in and out of liquid nitrogen (LN2) until the mixture is frozen; holding the vials at ?20° C.; placing the vials on a cooled shelf of a lyophilizer; freeze-drying the vials in the lyophilizer; and capping the freeze-dried vials.Type: GrantFiled: March 13, 2020Date of Patent: July 19, 2022Assignees: Thomas Jefferson University, Drexel UniversityInventors: Brian Edward Oeffinger, Margaret A. Wheatley, Rawan Shraim, Purva Vaidya, John Robert Eisenbrey
-
Publication number: 20220218825Abstract: The invention relates to an ultrasound contrast agent (UCA) comprising an outer shell and a gas core. The gas core is filled with oxygen, and the outer shell comprises a first surfactant and a second surfactant. The invention also relates to a method of making an oxygen-filled UCA and delivering oxygen to a local area of a subject's body. The method comprises injecting a composition comprising an oxygen-filled UCA of the invention into the subject's body; directing ultrasound radiation to the local area in an intensity sufficient to rupture the UCA.Type: ApplicationFiled: March 29, 2022Publication date: July 14, 2022Applicants: Drexel University, Thomas Jefferson UniversityInventors: John Robert Eisenbrey, Margaret Alison Wheatley, Patrick O'Kane, Lorenzo Albala, Flemming Forsberg